Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles

References

• NieSUnderstanding and overcoming major barriers in cancer nanomedicineNanomedicine (Lond)20105452352820528447
   PubMed Web of Science ®Google Scholar
• StormGBelliotSODaemenTLasicDDSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte systemAdv Drug Deliv Rev19951713148
   Web of Science ®Google Scholar
• AllenTMHansenCMartinFRedemannCYau-YoungALiposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochim Biophys Acta19911066129362065067
   PubMed Web of Science ®Google Scholar
• WoodleMCLasicDDSterically stabilized liposomesBiochim Biophys Acta1992111321711991510996
   PubMed Web of Science ®Google Scholar
• StolnikSIllumLDavisSSLong circulating microparticulate drug carriersAdv Drug Deliv Rev1995162–3195214
   Web of Science ®Google Scholar
• LavermanPCarstensMGBoermanOCFactors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injectionJ Pharmacol Exp Ther2001298260761211454922
   PubMed Web of Science ®Google Scholar
• DamsETLavermanPOyenWJAccelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomesJ Pharmacol Exp Ther200029231071107910688625
   PubMed Web of Science ®Google Scholar
• IshiharaTTakedaMSakamotoHAccelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticlesPharm Res200926102270227919633820
   PubMed Web of Science ®Google Scholar
• LuWWanJSheZJiangXBrain delivery property and accelerated blood clearance of cationic albumin conjugated PEGylated nanoparticleJ Control Release20071181385317240471
   PubMed Web of Science ®Google Scholar
• KoideHAsaiTHatanakaKParticle size-dependent triggering of accelerated blood clearance phenomenonInt J Pharm20083621–219720018586076
   PubMed Web of Science ®Google Scholar
• TagamiTNakamuraKShimizuTIshidaTKiwadaHEffect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM productionJ Control Release2009137323424019361546
   PubMed Web of Science ®Google Scholar
• TagamiTUeharaYMoriyoshiNIshidaTKiwadaHAnti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNAJ Control Release2011151214915421223988
   PubMed Web of Science ®Google Scholar
• KaminskasLMMcLeodVMPorterCJBoydBJDifferences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearanceJ Pharm Sci2011100115069507721721002
   PubMed Web of Science ®Google Scholar
• MüllerRHMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• WongHLBendayanRRauthAMLiYWuXYChemotherapy with anticancer drugs encapsulated in solid lipid nanoparticlesAdv Drug Deliv Rev200759649150417532091
   PubMed Web of Science ®Google Scholar
• YangSCLuLFCaiYZhuJBLiangBWYangCZBody distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brainJ Control Release199959329930710332062
   PubMed Web of Science ®Google Scholar
• ParveenSMisraRSahooSKNanoparticles: a boon to drug delivery, therapeutics, diagnostics and imagingNanomedicine20128214716621703993
   PubMed Web of Science ®Google Scholar
• WongHLBendayanRRauthAMWuXYDevelopment of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizersJ Pharm Sci20049381993200815236449
   PubMed Web of Science ®Google Scholar
• KangKWChunMKKimODoxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapyNanomedicine20106221021320060074
   PubMed Web of Science ®Google Scholar
• WongHLBendayanRRauthAMXueHYBabakhanianKWuXYA mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle systemJ Pharmacol Exp Ther200631731372138116547167
   PubMed Web of Science ®Google Scholar
• ZhangXGMiaoJDaiYQDuYZYuanHHuFQReversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cellsInt J Pharm20083611–223924418586075
   PubMed Web of Science ®Google Scholar
• WongHLRauthAMBendayanRA new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cellsPharm Res20062371574158516786442
   PubMed Web of Science ®Google Scholar
• IshidaTIchiharaMWangXInjection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomesJ Control Release20061121152516515818
   PubMed Web of Science ®Google Scholar
• IshidaTWangXShimizuTNawataKKiwadaHPEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent mannerJ Control Release2007122334935517610982
   PubMed Web of Science ®Google Scholar
• KoideHAsaiTHatanakaKT cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomesInt J Pharm20103921–221822320227473
   PubMed Web of Science ®Google Scholar
• WangXIshidaTKiwadaHAnti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomesJ Control Release2007119223624417399838
   PubMed Web of Science ®Google Scholar
• IshidaTIchikawaTIchiharaMSadzukaYKiwadaHEffect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in miceJ Control Release200495340341215023452
   PubMed Web of Science ®Google Scholar
• IshidaTAtobeKWangXKiwadaHAccelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injectionJ Control Release2006115325125817045355
   PubMed Web of Science ®Google Scholar
• IshidaTHaradaMWangXYIchiharaMIrimuraKKiwadaHAccelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomesJ Control Release2005105330531715908032
   PubMed Web of Science ®Google Scholar
• SrodaKRydlewskiJLangnerMKozubekAGrzybekMSikorskiAFRepeated injections of PEG-PE liposomes generate anti-PEG antibodiesCell Mol Biol Lett2005101374715809678
   PubMed Web of Science ®Google Scholar
• ShimadaKMatsuoSSadzukaYDetermination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomesInt J Pharm20002031–225526310967447
   PubMed Web of Science ®Google Scholar
• SadzukaYNakadeATsurudaTSonobeTStudy on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicinJ Control Release200391327128012932707
   PubMed Web of Science ®Google Scholar
• AggarwalPHallJBMcLelandCBDobrovolskaiaMAMcNeilSENanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdv Drug Deliv Rev200961642843719376175
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• RoyKMaoHQHuangSKLeongKWOral gene delivery with chitosan: DNA nanoparticles generates immunologic protection in a murine model of peanut allergyNat Med19995438739110202926
   PubMed Web of Science ®Google Scholar
• Dos SantosNAllenCDoppenAMInfluence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein bindingBiochim Biophys Acta2007176861367137717400180
   PubMed Web of Science ®Google Scholar
• HumphreyJHTolerogenic or immunogenic activity of hapten-conjugated polysaccharides correlated with cellular localizationEur J Immunol19811132122207238567
   PubMed Web of Science ®Google Scholar
• MondJJVosQLeesASnapperCMT cell independent antigensCurr Opin Immunol1995733493547546399
   PubMed Web of Science ®Google Scholar
• BastenASilveiraPAB-cell tolerance: mechanisms and implicationsCurr Opin Immunol201022556657420829011
   PubMed Web of Science ®Google Scholar